Cargando…

Impact of Targeted Therapy on the Survival of Patients With Advanced-Stage Non-small Cell Lung Cancer in Oncosalud - AUNA

BACKGROUND: Lung cancer is still a prevalent and fatal neoplasm in developing countries. In the last decades, chemotherapy (CHT) maintenance occupied an important role in the treatment, as well as targeted therapies. We aimed to evaluate the survival impact of targeted therapy in advanced lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguilar, Alfredo, Mas, Luis, Enríquez, Daniel, Vallejos, Carlos, Gutarra, Rosa, Flores, Claudio J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777330/ https://www.ncbi.nlm.nih.gov/pubmed/35030060 http://dx.doi.org/10.1177/10732748211068637

Ejemplares similares

Life expectancy and cancer survival in Oncosalud: outcomes over a 15-year period in a Peruvian private institution
por: Colonio, Christian, et al.
Publicado: (2021)

Remodeling of the Inner Hair Cell Microtubule Meshwork in a Mouse Model of Auditory Neuropathy AUNA1
por: Surel, Clément, et al.
Publicado: (2016)

Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
por: Pinto, Joseph A, et al.
Publicado: (2018)

Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer
por: Araujo, Jhajaira M., et al.
Publicado: (2016)

Barriers in Latin America for the management of locally advanced breast cancer
por: Pinto, Joseph A, et al.
Publicado: (2019)

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)
por: Ruiz‐Patiño, Alejandro, et al.
Publicado: (2019)

Advances and controversies in the management of early stage non-small cell lung cancer
por: Cilleruelo-Ramos, Angel, et al.
Publicado: (2021)

Advances in radiological staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2004)

Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer
por: Pierret, Thomas, et al.
Publicado: (2020)

Real‐world KINDLE‐Latin America subset data on treatment patterns and clinical outcomes in patients with stage III non‐small‐cell lung cancer
por: Martin, Claudio Marcelo, et al.
Publicado: (2022)

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer
por: Shi, Huashan, et al.
Publicado: (2021)

Pulmonary atelectasis and survival in advanced non-small cell lung carcinoma
por: Bulbul, Yilmaz, et al.
Publicado: (2010)

Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?
por: Ordu, Cetin, et al.
Publicado: (2014)

The Impact of Social Determinants of Health, Namely Financial Assistance, on Overall Survival in Advanced-Stage Non-Small Cell Lung Cancer Patients
por: Bello, Andreas, et al.
Publicado: (2023)

Effect of stage shift and immunotherapy treatment on lung cancer survival outcomes
por: Patel, Parth, et al.
Publicado: (2023)

Treatment Outcomes in Elderly with Advanced-Stage Non-small Cell Lung Cancer
por: Tam, Terence Chi-Chun, et al.
Publicado: (2013)

Impact of socioeconomic status on cancer staging, survival in non-small cell lung cancer
por: Yang, Xianghui, et al.
Publicado: (2022)

Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Sotelo, Miguel J, et al.
Publicado: (2021)

Control of cervical cancer in Peru: Current barriers and challenges for the future
por: Aguilar, Alfredo, et al.
Publicado: (2016)

Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung Cancer
por: Baudoux, Nathalie, et al.
Publicado: (2023)

Long-term Survival of Locally Advanced Stage III Non-small Cell Lung Cancer Patients Treated with Chemoradiotherapy and Perspectives for The Treatment with Immunotherapy
por: Vrankar, Martina, et al.
Publicado: (2018)

Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
por: Hayashi, Hidetoshi, et al.
Publicado: (2011)

Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices
por: Roque, Katia, et al.
Publicado: (2023)

Telemedicine and the current opportunities for the management of oncological patients in Peru in the context of COVID-19 pandemic
por: Montenegro, Paola, et al.
Publicado: (2021)

The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
por: Xia, Bing, et al.
Publicado: (2011)

Impact of subsequent chemotherapy on the survival of elderly patients with extensive stage small cell lung cancer
por: Kang, Eun Joo, et al.
Publicado: (2020)

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer
por: Hao, Bo, et al.
Publicado: (2020)

Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer
por: Li, Di, et al.
Publicado: (2021)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer
por: Gerber, D E, et al.
Publicado: (2013)

Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival
por: Kanaji, Nobuhiro, et al.
Publicado: (2016)

Evolution of Systemic Treatment Uptake and Survival in Advanced Non-Small Cell Lung Cancer
por: Stock-Martineau, Sophie, et al.
Publicado: (2020)

Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Jo, Hyunji, et al.
Publicado: (2022)

Association of heartbeat complexity with survival in advanced non-small cell lung cancer patients
por: Wu, Shuang, et al.
Publicado: (2023)

Surgery for stage IV non-small cell lung cancer?
por: Puig, Carlos A., et al.
Publicado: (2020)

A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus
por: Bang, Sun-Hwi, et al.
Publicado: (2012)

A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy
por: Rajakumar, Timothy, et al.
Publicado: (2022)

Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru
por: Galvez‐Nino, Marco, et al.
Publicado: (2022)

Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
por: Chhatre, Sumedha, et al.
Publicado: (2021)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

A nomogram for the prediction of the survival of patients with advanced non‐small cell lung cancer and interstitial lung disease
por: Xiu, Weigang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0v652r15bmu1nn8p9rnhv5ts6j